aid: formation name: Formation Bio description: >- Formation Bio is an AI-native pharmaceutical company building the pharma company of the future. Rather than applying AI to drug discovery, it focuses on drug development — acquiring and in-licensing clinical-stage drug candidates from pharma companies, universities, and biotech firms, then running them through clinical development far more efficiently than industry standards using its proprietary AI-native platform, data, and fine-tuned models. Led by CEO Benjamine Liu and CTO Linhao Zhang, the company raised a $372M Series D in 2024 led by a16z with participation from Sanofi, Sequoia, Thrive, Emerson Collective, and others, and partners with Sanofi and OpenAI on custom models for the drug development lifecycle. Formation Bio does not currently publish a public developer API; this profile tracks its identity and public web surface. url: https://raw.githubusercontent.com/api-evangelist/formation/refs/heads/main/apis.yml accessModel: pricing: unknown onboarding: unknown trial: false try_now: false public: false label: Unknown confidence: low source: [] generated: '2026-07-22' method: derived image: https://cdn.sanity.io/images/1oav6d5s/production/682b89b26ef34fc9cc89ca7c30f1044d429dab58-5542x8312.jpg?w=1200&h=630&fit=crop&auto=format x-type: company x-source: vc-portfolio x-backed-by: - a16z - felicis x-tier: stub x-tier-reason: portfolio-lead specificationVersion: '0.20' created: '2026-07-17' modified: '2026-07-19' tags: - Company - Pharmaceutical - Drug Development - Artificial Intelligence - Biotechnology - Healthcare - Clinical Trials apis: [] maintainers: - FN: Kin Lane email: kin@apievangelist.com - FN: APIs.json email: info@apis.io common: - type: DomainSecurity url: security/formation-domain-security.yml - type: Website url: https://formation.bio - type: Blog url: https://formation.bio/blog - type: PrivacyPolicy url: https://formation.bio/documents/privacy-policy x-enrichment: date: '2026-07-19' status: backfilled pass: local-v1 note: backfilled from .gitignore signal + verified work evidence